Share: Facebook Twitter LinkedIn
Activity Provided By:

EXCEL Continuing Education

Shifting the Paradigm in the Management of Beta-Thalassemia: Transitioning to a Young Adult

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of physicians, nurse practitioners, and other healthcare professionals who treat and/or manage patients with beta-thalassemia or who wish to increase their knowledge and competence regarding this genetic disease.

Program Overview
Thalassemias are a common cause of hypochromic microcytic anemia which arises from the reduced or absent synthesis of the globin chain of hemoglobin. This global chain imbalance eventually advances to iron overload leading to infections, fatigue, weakness, and even organs that do not function properly. This educational initiative intends to close β'thalassemia clinical care gaps when transitioning patient care from pediatrics into adulthood, as well as improving awareness of non-transfusion dependent treatments once patients age into adulthood, while gaining a better understanding of the patient’s journey and the impact this transition can have on treatment outcomes.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Assess genotype-phenotype correlations, disease severity and considerations for monitoring, using sample patient case scenarios
Recognize that β'thalassemia has 2 major classifications: transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT)
Identify the management barriers and needs of young adults with β-thalassemia when transitioning to adult academic and community treatment centers
Discuss existing and emerging treatments for β'thalassemia and how these therapies may be safely and effectively integrated into practice to deliver high quality care

Expiration

Jul 21, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Jeanne Boudreaux, MD
Kevin H.M. Kuo, MD, MSc, FRCPC

Sponsors / Supporters / Grant Providers

AGIOS PHARMACEUTICALS and CHIESI GLOBAL RARE DISEASES

Keywords / Search Terms

Relias LLC Relias, Free CME, beta-thalassemia, rare diseases Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map